Page 22 - GUAM NOC MADC - 2021 Draft Anti-Doping Rules

5.7 Independent Observer Program

GMADC and any organizing committees for National Events in Guam, shall authorize and facilitate
the Independent Observer Program at such Events.

ARTICLE 6 ANALYSIS OF SAMPLES

Samples shall be analyzed in accordance with the following principles:

6.1 Use of Accredited, Approved Laboratories and Other Laboratories

6.1.1 For purposes of directly establishing an Adverse Analytical Finding under Article
2.1, Samples shall be analyzed only in WADA-accredited laboratories or
laboratories otherwise approved by WADA. The choice of the WADA-accredited
or WADA-approved laboratory used for the Sample analysis shall be determined
exclusively by GMADC.
30

6.1.2 As provided in Article 3.2, facts related to anti-doping rule violations may be
established by any reliable means. This would include, for example, reliable
laboratory or other forensic testing conducted outside of WADA-accredited or
approved laboratories.

6.2 Purpose of Analysis of Samples and Data

Samples and related analytical data or Doping Control information shall be analyzed to detect
Prohibited Substances and Prohibited Methods identified on the Prohibited List and other
substances as may be directed by WADA pursuant to the monitoring program described in Article
4.5 of the Code, or to assist GMADC in profiling relevant parameters in an Athlete’s urine, blood or
other matrix, including for DNA or genomic profiling, or for any other legitimate anti-doping
31
purpose.

6.3 Research on Samples and Data

Samples, related analytical data and Doping Control information may be used for anti-doping
research purposes, although no Sample may be used for research without the Athlete's written
consent. Samples and related analytical data or Doping Control information used for research
purposes shall first be processed in such a manner as to prevent Samples and related analytical
data or Doping Control information being traced back to a particular Athlete. Any research involving
Samples and related analytical data or Doping Control information shall adhere to the principles
set out in Article 19 of the Code.
32

30 [Comment to Article 6.1: Violations of Article 2.1 may be established only by Sample analysis performed by a WADA-accredited
laboratory or another laboratory approved by WADA. Violations of other Articles may be established using analytical results
from other laboratories so long as the results are reliable.]

31 [Comment to Article 6.2.1: For example, relevant Doping Control-related information could be used to direct Target Testing or
to support an anti-doping rule violation proceeding under Article 2.2, or both.]

32 [Comment to Article 6.3: As is the case in most medical or scientific contexts, use of Samples and related information for quality
assurance, quality improvement, method improvement and development or to establish reference populations is not considered
research. Samples and related information used for such permitted non-research purposes must also first be processed in
such a manner as to prevent them from being traced back to the particular Athlete, having due regard to the principles set out
in Article 19 of the Code, as well as the requirements of the International Standard for Laboratories and International Standard
for the Protection of Privacy and Personal Information.]

2021 GUAM NOC ANTI-DOPING RULES Page 22 of 70